211 related articles for article (PubMed ID: 25259713)
1. Osteoprotegerin, pericytes and bone-like vascular calcification are associated with carotid plaque stability.
Davaine JM; Quillard T; Brion R; Lapérine O; Guyomarch B; Merlini T; Chatelais M; Guilbaud F; Brennan MÁ; Charrier C; Heymann D; Gouëffic Y; Heymann MF
PLoS One; 2014; 9(9):e107642. PubMed ID: 25259713
[TBL] [Abstract][Full Text] [Related]
2. Bone Like Arterial Calcification in Femoral Atherosclerotic Lesions: Prevalence and Role of Osteoprotegerin and Pericytes.
Davaine JM; Quillard T; Chatelais M; Guilbaud F; Brion R; Guyomarch B; Brennan MÁ; Heymann D; Heymann MF; Gouëffic Y
Eur J Vasc Endovasc Surg; 2016 Feb; 51(2):259-67. PubMed ID: 26652270
[TBL] [Abstract][Full Text] [Related]
3. Distribution of alkaline phosphatase, osteopontin, RANK ligand and osteoprotegerin in calcified human carotid atheroma.
Higgins CL; Isbilir S; Basto P; Chen IY; Vaduganathan M; Vaduganathan P; Reardon MJ; Lawrie G; Peterson L; Morrisett JD
Protein J; 2015 Oct; 34(5):315-28. PubMed ID: 26307009
[TBL] [Abstract][Full Text] [Related]
4. Association between Pericytes in Intraplaque Neovessels and Magnetic Resonance Angiography Findings.
Ogata A; Wakamiya T; Nishihara M; Tanaka T; Mizokami T; Masuoka J; Momozaki N; Sakata S; Irie H; Abe T
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183204
[TBL] [Abstract][Full Text] [Related]
5. The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability.
Kadoglou NP; Gerasimidis T; Golemati S; Kapelouzou A; Karayannacos PE; Liapis CD
J Vasc Surg; 2008 Jan; 47(1):55-62. PubMed ID: 18178454
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the genetic effects of polymorphisms in the osteoprotegerin gene, TNFRSF11B, on serum osteoprotegerin levels and carotid plaque vulnerability.
Straface G; Biscetti F; Pitocco D; Bertoletti G; Misuraca M; Vincenzoni C; Snider F; Arena V; Stigliano E; Angelini F; Iuliano L; Boccia S; de Waure C; Giacchi F; Ghirlanda G; Flex A
Stroke; 2011 Nov; 42(11):3022-8. PubMed ID: 21903966
[TBL] [Abstract][Full Text] [Related]
7. Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans.
Vik A; Mathiesen EB; Notø AT; Sveinbjørnsson B; Brox J; Hansen JB
Atherosclerosis; 2007 Mar; 191(1):128-34. PubMed ID: 16620835
[TBL] [Abstract][Full Text] [Related]
8. Elevated Circulating Osteoprotegerin Levels in the Plasma of Hemodialyzed Patients With Severe Artery Calcification.
Krzanowski M; Krzanowska K; Dumnicka P; Gajda M; Woziwodzka K; Fedak D; Grodzicki T; Litwin JA; Sułowicz W
Ther Apher Dial; 2018 Oct; 22(5):519-529. PubMed ID: 29974642
[TBL] [Abstract][Full Text] [Related]
9. TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL.
Di Bartolo BA; Cartland SP; Harith HH; Bobryshev YV; Schoppet M; Kavurma MM
PLoS One; 2013; 8(9):e74211. PubMed ID: 24040204
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin and osteoprotegerin in atherosclerotic plaque - are they significant markers of plaque vulnerability?
Strobescu-Ciobanu C; Giuşcă SE; Căruntu ID; Amălinei C; Rusu A; Cojocaru E; Popa RF; Lupaşcu CD
Rom J Morphol Embryol; 2020; 61(3):793-801. PubMed ID: 33817720
[TBL] [Abstract][Full Text] [Related]
11. The expression of glycophorin A and osteoprotegerin is locally increased in carotid atherosclerotic lesions of symptomatic compared to asymptomatic patients.
Hakimi M; Hyhlik-Dürr A; von Au A; Betz M; Demirel S; Dihlmann S; Böckler D; Gross-Weissmann ML
Int J Mol Med; 2013 Aug; 32(2):331-8. PubMed ID: 23722820
[TBL] [Abstract][Full Text] [Related]
12. Circulating osteoprotegerin and asymptomatic carotid atherosclerosis in postmenopausal non diabetic women.
Albu A; Bondor CI; Crăciun AM; Fodor D
Adv Med Sci; 2014 Sep; 59(2):293-8. PubMed ID: 25240503
[TBL] [Abstract][Full Text] [Related]
13. Coexistence of Calcification, Intraplaque Hemorrhage and Lipid Core within the Asymptomatic Atherosclerotic Carotid Plaque: The Rotterdam Study.
van den Bouwhuijsen QJ; Bos D; Ikram MA; Hofman A; Krestin GP; Franco OH; van der Lugt A; Vernooij MW
Cerebrovasc Dis; 2015; 39(5-6):319-24. PubMed ID: 25966822
[TBL] [Abstract][Full Text] [Related]
14. Vascular calcification in type-2 diabetes and cardiovascular disease: Integrative roles for OPG, RANKL and TRAIL.
Harper E; Forde H; Davenport C; Rochfort KD; Smith D; Cummins PM
Vascul Pharmacol; 2016 Jul; 82():30-40. PubMed ID: 26924459
[TBL] [Abstract][Full Text] [Related]
15. Relationship between Calcification and Vulnerability of the Carotid Plaques.
Pini R; Faggioli G; Fittipaldi S; Vasuri F; Longhi M; Gallitto E; Pasquinelli G; Gargiulo M; Stella A
Ann Vasc Surg; 2017 Oct; 44():336-342. PubMed ID: 28479433
[TBL] [Abstract][Full Text] [Related]
16. Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification.
Pérez de Ciriza C; Moreno M; Restituto P; Bastarrika G; Simón I; Colina I; Varo N
Clin Biochem; 2014 Dec; 47(18):272-8. PubMed ID: 25218813
[TBL] [Abstract][Full Text] [Related]
17. Crystallizing nanoparticles derived from vascular smooth muscle cells contain the calcification inhibitor osteoprotegerin.
Schoppet M; Kavurma MM; Hofbauer LC; Shanahan CM
Biochem Biophys Res Commun; 2011 Apr; 407(1):103-7. PubMed ID: 21371424
[TBL] [Abstract][Full Text] [Related]
18. Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis.
Golledge J; McCann M; Mangan S; Lam A; Karan M
Stroke; 2004 Jul; 35(7):1636-41. PubMed ID: 15143295
[TBL] [Abstract][Full Text] [Related]
19. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
20. Carotid Plaque Morphology Is Significantly Associated With Sex, Age, and History of Neurological Symptoms.
Wendorff C; Wendorff H; Pelisek J; Tsantilas P; Zimmermann A; Zernecke A; Kuehnl A; Eckstein HH
Stroke; 2015 Nov; 46(11):3213-9. PubMed ID: 26451032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
